The Pharmafocus Interview: Jan Lundberg AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
Trained to win Monday , November 13, 2006
Training budgets are often the first to be cut when times are lean, but this could be just when staff need to perform better. John Hosken gauges the current state of sales and marketing training...(more)
UK biotech comes to market Friday , November 10, 2006
An AIM flotation can raise useful funds for re-investment, but it needs careful forethought and planning. Stephen Rosen and Tom Crease look at the pros and cons of going public.
...(more)
First class relationships Monday , November 06, 2006
What can pharma do to make the most of its precious relationships with clinicians and key opinion leaders ? Agency frontliners give us their views....(more)
Has pharma got the feelgood factor? Wednesday, November 01, 2006
Satisfied workers are the key to business success, but this requires insight into what people expect and an ability to give them what they want, says John Hosken....(more)
Pharma's evolving relationship with NICE Wednesday, November 01, 2006
NICE's new fast-track process should continue the improvement seen in its relations with pharma, but the industry still harbours some concerns, says Dominic Tyer....(more)
